Gene-editing drugs advance quickly, but face major challenges
Summary: Gene-editing drugs are rapidly advancing from research to clinical trials, offering hope for conditions like amyloidosis. In 2020, Patrick Doherty, diagnosed with the disease, participated in a trial and was reportedly cured after a single injection. Despite the promise of these therapies, they still encounter significant technical and economic challenges before widespread availability.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings